drugset / Trial / NCT06712121
Venetoclax and Decitabine in R/R T-ALL
Phase 2
Recruiting
28 enrolled
Seoul National University Hospital
Korean Society of Hematology · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this phase 2 clinical trial is to test the efficacy of decitabine and venetoclax combination chemotherapy in relapsed or refractory adult T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. This study use a modified regimen of decitabine and venetoclax.
Timeline
- Start
- 2025-01-30
- Primary completion
- 2027-08-31
- Completion
- 2028-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 20 mg/m2 | — |
| Subject | Venetoclax | Small molecule | 400 mg | — |